BeStock  
Markets › Compare › PBYI vs CTMX

PBYI vs CTMX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PBYI · Puma Biotechnology$9.60 ▼ 2.19%
CTMX · CytomX$2.46 ▼ 3.73%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

67101135169203Oct 9, '25Apr 9, '26Oct 7, '26
  • PBYI +88.3%
  • CTMX -26.1%

Head to head

MetricPBYICTMX
Price$9.60$2.46
Change today▼ 2.19%▼ 3.73%
Market cap$495.29M$534.94M
Return, 3 months+21.5%-37.9%
Return, year to date+61.3%-42.4%
Return, 1 year+83.5%-27.2%
P/E (TTM)18.8-4.3
P/B3.61.8
P/E percentile vs own 5y–25th
Dividend yield––
Revenue growth (YoY, latest qtr)–-92.4%
Net profit growth (YoY)–-13,319.5%
Gross margin––
Operating margin–-476.2%
Net margin–-435.2%
Return on equity–-37.8%
Analyst target vs. price–+439.7%
Analyst buy share–100%
RSI (14)5732
30-day volatility37.7%72.2%
Max drawdown, 1 year-25.8%-62.2%
Trend readStrong uptrendStrong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CTMX is the largest of the group by market value.
  • PBYI has returned the most over the past year.
  • CTMX carries the lowest trailing P/E.
  • PBYI has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top